215 related articles for article (PubMed ID: 31219225)
1. Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium.
Young KA; Palmer ND; Fingerlin TE; Langefeld CD; Norris JM; Wang N; Xiang AH; Guo X; Williams AH; Chen YI; Taylor KD; Rotter JI; Raffel LJ; Goodarzi MO; Watanabe RM; Wagenknecht LE
Obesity (Silver Spring); 2019 Aug; 27(8):1331-1337. PubMed ID: 31219225
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
[TBL] [Abstract][Full Text] [Related]
3. PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population.
Li Q; Qu HQ; Rentfro AR; Grove ML; Mirza S; Lu Y; Hanis CL; Fallon MB; Boerwinkle E; Fisher-Hoch SP; McCormick JB
Clin Invest Med; 2012 Aug; 35(4):E237-45. PubMed ID: 22863562
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
Kitamoto T; Kitamoto A; Yoneda M; Hyogo H; Ochi H; Nakamura T; Teranishi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A; Hotta K
Hum Genet; 2013 Jul; 132(7):783-92. PubMed ID: 23535911
[TBL] [Abstract][Full Text] [Related]
5. Heritability of liver enzyme levels estimated from genome-wide SNP data.
van Beek JH; Lubke GH; de Moor MH; Willemsen G; de Geus EJ; Hottenga JJ; ; Walters RK; Smit JH; Penninx BW; Boomsma DI
Eur J Hum Genet; 2015 Sep; 23(9):1223-8. PubMed ID: 25424715
[TBL] [Abstract][Full Text] [Related]
6. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
[TBL] [Abstract][Full Text] [Related]
7. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
[TBL] [Abstract][Full Text] [Related]
8. A common variant in the adiponutrin gene influences liver enzyme values.
Kollerits B; Coassin S; Kiechl S; Hunt SC; Paulweber B; Willeit J; Brandstätter A; Lamina C; Adams TD; Kronenberg F
J Med Genet; 2010 Feb; 47(2):116-9. PubMed ID: 19542081
[TBL] [Abstract][Full Text] [Related]
9. The genetic architecture of liver enzyme levels: GGT, ALT and AST.
van Beek JH; de Moor MH; de Geus EJ; Lubke GH; Vink JM; Willemsen G; Boomsma DI
Behav Genet; 2013 Jul; 43(4):329-39. PubMed ID: 23580007
[TBL] [Abstract][Full Text] [Related]
10. Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
Whitfield JB; Zhu G; Madden PAF; Montgomery GW; Heath AC; Martin NG
Alcohol Clin Exp Res; 2019 Mar; 43(3):473-482. PubMed ID: 30589442
[TBL] [Abstract][Full Text] [Related]
11. American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults.
Kallwitz ER; Tayo BO; Kuniholm MH; Cai J; Daviglus M; Cooper RS; Cotler SJ
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2301-2309. PubMed ID: 30743004
[TBL] [Abstract][Full Text] [Related]
12. PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.
Larrieta-Carrasco E; Acuña-Alonzo V; Velázquez-Cruz R; Barquera-Lozano R; León-Mimila P; Villamil-Ramírez H; Menjivar M; Romero-Hidalgo S; Méndez-Sánchez N; Cárdenas V; Bañuelos-Moreno M; Flores YN; Quiterio M; Salmerón J; Sánchez-Muñoz F; Villarreal-Molina T; Aguilar-Salinas CA; Canizales-Quinteros S
Mol Biol Rep; 2014 Jul; 41(7):4705-11. PubMed ID: 24691744
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population.
Chung GE; Lee Y; Yim JY; Choe EK; Kwak MS; Yang JI; Park B; Lee JE; Kim JA; Kim JS
Gut Liver; 2018 May; 12(3):316-323. PubMed ID: 29271184
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide association study on liver enzymes in Korean population.
Seo JY; Lee JE; Chung GE; Shin E; Kwak MS; Yang JI; Yim JY
PLoS One; 2020; 15(2):e0229374. PubMed ID: 32084209
[TBL] [Abstract][Full Text] [Related]
16. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
Serper M; Vujkovic M; Kaplan DE; Carr RM; Lee KM; Shao Q; Miller DR; Reaven PD; Phillips LS; O'Donnell CJ; Meigs JB; Wilson PWF; Vickers-Smith R; Kranzler HR; Justice AC; Gaziano JM; Muralidhar S; Pyarajan S; DuVall SL; Assimes TL; Lee JS; Tsao PS; Rader DJ; Damrauer SM; Lynch JA; Saleheen D; Voight BF; Chang KM;
PLoS One; 2020; 15(8):e0237430. PubMed ID: 32841307
[TBL] [Abstract][Full Text] [Related]
17. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
Namjou B; Lingren T; Huang Y; Parameswaran S; Cobb BL; Stanaway IB; Connolly JJ; Mentch FD; Benoit B; Niu X; Wei WQ; Carroll RJ; Pacheco JA; Harley ITW; Divanovic S; Carrell DS; Larson EB; Carey DJ; Verma S; Ritchie MD; Gharavi AG; Murphy S; Williams MS; Crosslin DR; Jarvik GP; Kullo IJ; Hakonarson H; Li R; ; Xanthakos SA; Harley JB
BMC Med; 2019 Jul; 17(1):135. PubMed ID: 31311600
[TBL] [Abstract][Full Text] [Related]
18. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.
Sookoian S; Pirola CJ
World J Gastroenterol; 2015 Jan; 21(3):711-25. PubMed ID: 25624707
[TBL] [Abstract][Full Text] [Related]
19. Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.
Seko Y; Yamaguchi K; Mizuno N; Okuda K; Takemura M; Taketani H; Hara T; Umemura A; Nishikawa T; Moriguchi M; Yasui K; Kamaguchi M; Nishioji K; Mochizuki N; Kobayashi M; Mori K; Tanaka S; Matsuura K; Tanaka Y; Itoh Y
J Gastroenterol; 2018 Mar; 53(3):438-448. PubMed ID: 28744823
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association analysis of serum alanine and aspartate aminotransferase, and the modifying effects of BMI in 388k European individuals.
Gao C; Marcketta A; Backman JD; O'Dushlaine C; Staples J; Ferreira MAR; Lotta LA; Overton JD; Reid JG; Mirshahi T; Regeneron Genetics Center ; Geisinger Regeneron Discovehr Collaboration ; Baras A; Abecasis G; Shuldiner AR; Van Hout CV; McCarthy S
Genet Epidemiol; 2021 Sep; 45(6):664-681. PubMed ID: 34184762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
